Try
Neurocrine Biosciences Inc.
NBIXUnited States
41 filed reports · 474 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
41 reports · Jun 2016 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 31 | 4,337 | Jun 2016 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 4,176 | Dec 2016 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 31, 2026 | 371 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 223 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 11, 2026 | 847 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 28, 2025 | 249 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 30, 2025 | 158 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 155 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 10, 2025 | 401 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Oct 30, 2024 | 159 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 1, 2024 | 150 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 1, 2024 | 160 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 9, 2024 | 419 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Oct 31, 2023 | 166 | Open |
Financial data
474 concepts · 8,513 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial457 concepts · 8,269 facts · Dec 2014 to Jul 2026
- Cash and cash equivalents at carrying value58 · Dec 2014 to Jun 2026
- Net income loss58 · Dec 2014 to Jun 2026
- Revenue58 · Dec 2014 to Jun 2026
- Comprehensive income net of tax57 · Dec 2014 to Jun 2026
- Nonoperating income expense57 · Dec 2014 to Jun 2026
- Operating income loss57 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities56 · Dec 2014 to Jun 2026
- Payments to acquire property plant and equipment56 · Dec 2014 to Jun 2026
- Proceeds from issuance of common stock56 · Dec 2014 to Jun 2026
- Share based compensation56 · Dec 2014 to Jun 2026
- Stockholders equity (US GAAP)55 · Dec 2014 to Jun 2026
- Accumulated other comprehensive income loss net of tax53 · Dec 2015 to Jun 2026
- Additional paid in capital common stock53 · Dec 2015 to Jun 2026
- Assets53 · Dec 2015 to Jun 2026
- Assets current53 · Dec 2015 to Jun 2026
- Common stock par or stated value per share53 · Dec 2015 to Jun 2026
- Common stock shares authorized53 · Dec 2015 to Jun 2026
- Common stock shares issued53 · Dec 2015 to Jun 2026
- Common stock shares outstanding53 · Dec 2015 to Jun 2026
- Common stock value53 · Dec 2015 to Jun 2026
- Liabilities53 · Dec 2015 to Jun 2026
- Liabilities and stockholders equity53 · Dec 2015 to Jun 2026
- Liabilities current53 · Dec 2015 to Jun 2026
- Other assets current53 · Dec 2015 to Jun 2026
Segment14 concepts · 145 facts · Dec 2022 to Jun 2026
- Equity securities fv ni unrealized gain loss14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Investment income and other, net14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Research and development asset acquired other than through business combination written off14 · Dec 2022 to Jun 2026
- Research and development expense excluding acquired in process cost14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Selling general and administrative expense14 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)13 · Dec 2022 to Mar 2026
- Charges associated with convertible senior notes12 · Dec 2022 to Dec 2025
- Amortization of intangible assets2 · Jun 2025 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization2 · Jun 2025 to Jun 2026
- Gain loss on sale of business2 · Jun 2025 to Jun 2026
- Interest expense nonoperating2 · Jun 2025 to Jun 2026
Product3 concepts · 99 facts · Dec 2016 to Jun 2026
- Revenue93 · Dec 2016 to Jun 2026
- Advertising expense4 · Dec 2017 to Dec 2019
- Ingrezza2 · Dec 2018 to Dec 2019
Segments
244 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 145 facts
- Reportable145 · Dec 2022 to Jun 2026
Product or servicesrt:ProductOrServiceAxis4 members · 98 facts
- Product46 · Dec 2016 to Jun 2026
- Collaboration Revenue44 · Dec 2016 to Jun 2026
- Ingrezza5 · Dec 2017 to Dec 2019
- INGREZZA3 · Dec 2022 to Dec 2024
Product or serviceus-gaap:ProductOrServiceAxis1 member · 1 facts
- Ingrezza1 · Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary99 claims from 8 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary157 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes17 claims from 1 reports · Dec 2025
- Risk factors80 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
- FY2026 Q1May 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.